TITLE

C07 Localisation of sequence variations in PGC-1α influence their modifying effect in Huntington's disease

AUTHOR(S)
Metzger, S; Van Che, H; Deyle, C; Riess, O; Nguyen, H P
PUB. DATE
September 2010
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Sep2010 Supp, Vol. 81, pA18
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background A polyglutamine repeat expansion of more than 36 units in the huntingtin protein is the only known cause of Huntington's disease (HD). The expanded repeat length is inversely correlated with the age at onset (AAO) but additional genetic factors apart from the expanded CAG repeat length can modify the course and AAO in HD. Until now, among others the gene encoding PCG-1α, a transcriptional coactivator in metabolic processes that seems to be defective in HD, could be identified to modify the AAO in two independent populations. Aim/method As the identification of distinct modifiers in association studies is generally dependent on the size of the observed population, we investigated nine different single nucleotide polymorphisms (SNP) in the PGC-1α gene for a disease modifying effect in more than 800 European HD patients. Results Two SNPs, one in the promotor and one in the transcribed region of the PGC-1α gene, showed a significant effect on the AAO. While the variant allele of SNP rs7665116 was associated with a delay in disease onset, the variant allele of SNP rs2970870 leads to an earlier onset of HD in its homozygous state. Conclusion Therefore, our results indicate opposing modifying influences of one gene to disease pathology and support the concept of a reduced PGC-1α expression due to mutant huntingtin as well as an altered functionality of PGC-1α towards target genes in HD pathogenesis.
ACCESSION #
66321978

 

Related Articles

  • PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease. Taherzadeh-Fard, Elahe; Saft, Carsten; Akkad, Denis A.; Wieczorek, Stefan; Haghikia, Aiden; Chan, Andrew; Epplen, Jörg T.; Arning, Larissa // Molecular Neurodegeneration;2011, Vol. 6 Issue 1, p32 

    Background: Huntington disease (HD) is an inherited neurodegenerative disease caused by an abnormal expansion of a CAG repeat in the huntingtin HTT (HD) gene. The primary genetic determinant of the age at onset (AO) is the length of the HTT CAG repeat; however, the remaining genetic contribution...

  • PGC-1alpha as modifier of onset age in Huntington disease. Taherzadeh-Fard, Elahe; Saft, Carsten; Andrich, Jürgen; Wieczorek, Stefan; Arning, Larissa // Molecular Neurodegeneration;2009, Vol. 4, p1 

    Although there is a strong correlation between CAG repeat length and age at onset (AO) of motor symptoms, individual Huntington disease (HD) patients may differ dramatically in onset age and disease manifestations despite similar CAG repeat lengths. This has led to a search for genetic factors...

  • Huntington's Disease – Making Connections. Greenamyre, J. Timothy // New England Journal of Medicine;2/1/2007, Vol. 356 Issue 5, p518 

    The article presents information on Huntington's disease. Such disease results from the expansion of a coronary angiography trinucleotide repeat in exon 1 of the gene which encodes huntingtin protein. However, a competing hypothesis exists, stating that Huntington's disease is caused by...

  • Hope for Huntington's Patients. Soares, Christine // Discover;Jan2002, Vol. 23 Issue 1, p54 

    Reports on the experiments made by scientists on the treatment of Huntington's Disease in the United States. Effects of Huntington's disease on the patient; Mutation of genes; Performance of gene sequences.

  • Genetic analysis of candidate genes modifying the age-at-onset in Huntington’s disease. Metzger, Silke; Bauer, Peter; Tomiuk, Jürgen; Laccone, Franco; DiDonato, Stefano; Gellera, Cinzia; Mariotti, Caterina; Lange, Herwig; Weirich-Schwaiger, Helga; Wenning, Gregor; Seppi, Klaus; Melegh, Bela; Havasi, Viktoria; Balikó, Laszlo; Wieczorek, Stefan; Zaremba, Jacek; Hoffman-Zacharska, Dorota; Sulek, Anna; Basak, A.; Soydan, Esra // Human Genetics;Sep2006, Vol. 120 Issue 2, p285 

    The expansion of a polymorphic CAG repeat in the HD gene encoding huntingtin has been identified as the major cause of Huntington’s disease (HD) and determines 42–73% of the variance in the age-at-onset of the disease. Polymorphisms in huntingtin interacting or associated genes are...

  • Localization of sequence variations in PGC-1α influence their modifying effect in Huntington disease. Che, Hong Van B.; Metzger, Silke; Portal, Esteban; Deyle, Carolin; Riess, Olaf; Huu Phuc Nguyen // Molecular Neurodegeneration;2011, Vol. 6 Issue 1, p1 

    Background: Huntington disease (HD) is caused by a polyglutamine expansion of more than 35 units in the huntingtin protein. This expanded repeat length inversely correlates with the age-at-onset (AAO), however, additional genetic factors apart from the expanded CAG repeat size are thought to...

  • 72: Protein Boost Halts Huntington's. NEIMARK, JILL // Discover;Jan/Feb2013, Vol. 34 Issue 1, p68 

    The article discusses 2012 research into the development of PGC-1-alpha protein supplements to treat Huntington's disease, which was researched at the University of California, San Diego.

  • A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohort. Weydt, Patrick; Soyal, Selma M.; Landwehrmeyer, G. Bernhard; Patsch, Wolfgang // BMC Neurology;2014, Vol. 14 Issue 1, p1 

    Background Genetic modifiers are important clues for the identification of therapeutic targets in neurodegenerative diseases. Huntington disease (HD) is one of the most common autosomal dominant inherited neurodegenerative diseases. The clinical symptoms include motor abnormalities, cognitive...

  • Developmental Alterations in Motor Coordination and Medium Spiny Neuron Markers in Mice Lacking PGC-1 α. Lucas, Elizabeth K.; Dougherty, Sarah E.; McMeekin, Laura J.; Trinh, Alisa T.; Reid, Courtney S.; Cowell, Rita M.; Coleman, Melissa J. // PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1 

    Accumulating evidence implicates the transcriptional coactivator peroxisome proliferator activated receptor γ coactivator 1α (PGC- 1α) in the pathophysiology of Huntington Disease (HD). Adult PGC-1α -/- mice exhibit striatal neurodegeneration, and reductions in the expression of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics